Latest Update: Impact of current COVID-19 situation has been considered in this report while making the analysis.
Global Nicotinic Agonists Market by Type (Nicotine, Acetylcholine, Carbachol, Epibatidine, Others), By Application (Alzheimer’s Disease (AD), Schizophrenia, Others) and Region (North America, Latin America, Europe, Asia Pacific and Middle East & Africa), Forecast From 2022 To 2030-report

Global Nicotinic Agonists Market by Type (Nicotine, Acetylcholine, Carbachol, Epibatidine, Others), By Application (Alzheimer’s Disease (AD), Schizophrenia, Others) and Region (North America, Latin America, Europe, Asia Pacific and Middle East & Africa), Forecast From 2022 To 2030

Report ID: 449693 4200 Pharma & Healthcare 377 250 Pages 4.6 (31)

Market Overview:

The global nicotinic agonists market is expected to grow at a CAGR of 5.5% during the forecast period from 2018 to 2030. The growth in this market can be attributed to the increasing prevalence of Alzheimer’s disease (AD) and schizophrenia, and the growing demand for novel therapies for these diseases. Nicotine is currently the most commonly used nicotinic agonist in therapeutics, owing to its well-known effects on cognitive function and memory. However, acetylcholine, carbachol, epibatidine, and other nicotinic agonists are also being developed as potential treatments for various diseases. These drugs are being investigated for their potential use in treating a range of conditions such as AD, schizophrenia, pain relief, smoking cessation, and others. Regionally speaking North America dominates the global nicotinic agonists market followed by Europe due to high prevalence rates of AD and schizophrenia in these regions respectively .

Global Nicotinic Agonists Industry Outlook

Product Definition:

A nicotinic agonist is a drug that binds to and activates the nicotinic acetylcholine receptors in the brain. These drugs are used to treat conditions such as Alzheimer's disease, Parkinson's disease, and Tourette's syndrome. The importance of nicotinic agonists is that they can improve symptoms in patients with these diseases by increasing the activity of acetylcholine receptors in the brain.


Nicotine is a chemical that is found in the leaves of tobacco and in some plants. It's main function is to protect the plant from being eaten by insects. Nicotine also helps the plant to grow, so that it can have more seeds to produce more tobacco for its master (the smoker). The amount of nicotine present in different types of cigarettes varies widely; one brand may have as much as 15 mg while another brand may contain only 2-3 mg.


Acetylcholine is an important neuromuscular transmission chemical. It is also a precursor for the synthesis of many important pharmaceutical drugs such as paracetamol, phenoxyethanol, and ethanol (as well as some natural products). The global acetylcholine market size spans application areas in multiple sectors including healthcare & medical sector.

Application Insights:

The others segment dominated the global nicotinic agonists market in terms of revenue in 2017. This is due to the presence of products for other medical conditions such as Parkinson¢â‚¬â„¢s disease, multiple sclerosis, and diabetes. In addition, this segment also includes a product for smoking cessation which is yet to be approved by the U.S FDA under section Quaalude Tablets (umais) brand name.

Alzheimer¢â‚¬â„¢s disease (AD) application was one of the major segments that contributed significantly towards revenue growth in 2017 owing to increasing geriatric population base and rising prevalence rate across the globe.

Regional Analysis:

North America dominated the global market in 2017. The region is expected to maintain its position during the forecast period owing to high awareness levels regarding mental disorders, availability of effective treatment methods, and rising disposable income. Moreover, increasing government initiatives for nicotine replacement therapy (NRT) are also anticipated to boost product demand in this region. For instance, the U.S Food and Drug Administration (FDA) has approved two products under this brand name - Nicorette chewing gums that deliver nicotine via lozenges and Nicotinell nasal spray that contains a combination of bupropion hydrochloride and nicotinamide adenine dinucleotide phosphate (NADP).

Growth Factors:

  • Increasing smoking population: The number of smokers is increasing globally, especially in the developing countries. This will drive the demand for nicotinic agonists as smoking cessation therapies.
  • Rising awareness about the health hazards of smoking: There is a growing awareness among people about the health hazards of smoking. This is driving them to seek effective quitting methods, such as nicotinic agonists.
  • Growing research and development activities: The pharmaceutical companies are investing heavily in research and development activities to develop better-quality nicotinic agonists products. This will help in expanding the market for these drugs in future years.

Scope Of The Report

Report Attributes

Report Details

Report Title

Nicotinic Agonists Market Research Report

By Type

Nicotine, Acetylcholine, Carbachol, Epibatidine, Others

By Application

Alzheimer's Disease (AD), Schizophrenia, Others

By Companies

FORUM Pharmaceuticals, Karuna Pharmaceuticals, Sumitomo Dainippon Pharma Co, BMS, Oyster Point Pharma, Jiangsu Hansoh Pharmaceutical, Dalian Meilun Biotech Co

Regions Covered

North America, Europe, APAC, Latin America, MEA

Base Year


Historical Year

2019 to 2020 (Data from 2010 can be provided as per availability)

Forecast Year


Number of Pages


Number of Tables & Figures


Customization Available

Yes, the report can be customized as per your need.

Global Nicotinic Agonists Market Report Segments:

The global Nicotinic Agonists market is segmented on the basis of:


Nicotine, Acetylcholine, Carbachol, Epibatidine, Others

The product segment provides information about the market share of each product and the respective CAGR during the forecast period. It lays out information about the product pricing parameters, trends, and profits that provides in-depth insights of the market. Furthermore, it discusses latest product developments & innovation in the market.


Alzheimer's Disease (AD), Schizophrenia, Others

The application segment fragments various applications of the product and provides information on the market share and growth rate of each application segment. It discusses the potential future applications of the products and driving and restraining factors of each application segment.

Some of the companies that are profiled in this report are:

  1. FORUM Pharmaceuticals
  2. Karuna Pharmaceuticals
  3. Sumitomo Dainippon Pharma Co
  4. BMS
  5. Oyster Point Pharma
  6. Jiangsu Hansoh Pharmaceutical
  7. Dalian Meilun Biotech Co

Global Nicotinic Agonists Market Overview

Highlights of The Nicotinic Agonists Market Report:

  1. The market structure and projections for the coming years.
  2. Drivers, restraints, opportunities, and current trends of market.
  3. Historical data and forecast.
  4. Estimations for the forecast period 2030.
  5. Developments and trends in the market.
  6. By Type:

    1. Nicotine
    2. Acetylcholine
    3. Carbachol
    4. Epibatidine
    5. Others
  1. By Application:

    1. Alzheimer's Disease (AD)
    2. Schizophrenia
    3. Others
  1. Market scenario by region, sub-region, and country.
  2. Market share of the market players, company profiles, product specifications, SWOT analysis, and competitive landscape.
  3. Analysis regarding upstream raw materials, downstream demand, and current market dynamics.
  4. Government Policies, Macro & Micro economic factors are also included in the report.

We have studied the Nicotinic Agonists Market in 360 degrees via. both primary & secondary research methodologies. This helped us in building an understanding of the current market dynamics, supply-demand gap, pricing trends, product preferences, consumer patterns & so on. The findings were further validated through primary research with industry experts & opinion leaders across countries. The data is further compiled & validated through various market estimation & data validation methodologies. Further, we also have our in-house data forecasting model to predict market growth up to 2030.

Regional Analysis

  • North America
  • Europe
  • Asia Pacific
  • Middle East & Africa
  • Latin America

Note: A country of choice can be added in the report at no extra cost. If more than one country needs to be added, the research quote will vary accordingly.

The geographical analysis part of the report provides information about the product sales in terms of volume and revenue in regions. It lays out potential opportunities for the new entrants, emerging players, and major players in the region. The regional analysis is done after considering the socio-economic factors and government regulations of the countries in the regions.

How you may use our products:

  • Correctly Positioning New Products
  • Market Entry Strategies
  • Business Expansion Strategies
  • Consumer Insights
  • Understanding Competition Scenario
  • Product & Brand Management
  • Channel & Customer Management
  • Identifying Appropriate Advertising Appeals

Global Nicotinic Agonists Market Statistics

8 Reasons to Buy This Report

  1. Includes a Chapter on the Impact of COVID-19 Pandemic On the Market
  2. Report Prepared After Conducting Interviews with Industry Experts & Top Designates of the Companies in the Market
  3. Implemented Robust Methodology to Prepare the Report
  4. Includes Graphs, Statistics, Flowcharts, and Infographics to Save Time
  5. Industry Growth Insights Provides 24/5 Assistance Regarding the Doubts in the Report
  6. Provides Information About the Top-winning Strategies Implemented by Industry Players.
  7. In-depth Insights On the Market Drivers, Restraints, Opportunities, and Threats
  8. Customization of the Report Available

Frequently Asked Questions?

Nicotinic agonists are drugs that bind to nicotinic receptors and cause a response in the body. These drugs can be used to treat conditions such as Alzheimer's disease, depression, and nicotine addiction.

Some of the major players in the nicotinic agonists market are FORUM Pharmaceuticals, Karuna Pharmaceuticals, Sumitomo Dainippon Pharma Co, BMS, Oyster Point Pharma, Jiangsu Hansoh Pharmaceutical, Dalian Meilun Biotech Co.

The nicotinic agonists market is expected to grow at a compound annual growth rate of 5.5%.

Chapter 1 Executive Summary
Chapter 2 Assumptions and Acronyms Used
Chapter 3 Research Methodology
Chapter 4 Nicotinic Agonists Market Overview    4.1 Introduction       4.1.1 Market Taxonomy       4.1.2 Market Definition       4.1.3 Macro-Economic Factors Impacting the Market Growth    4.2 Nicotinic Agonists Market Dynamics       4.2.1 Market Drivers       4.2.2 Market Restraints       4.2.3 Market Opportunity    4.3 Nicotinic Agonists Market - Supply Chain Analysis       4.3.1 List of Key Suppliers       4.3.2 List of Key Distributors       4.3.3 List of Key Consumers    4.4 Key Forces Shaping the Nicotinic Agonists Market       4.4.1 Bargaining Power of Suppliers       4.4.2 Bargaining Power of Buyers       4.4.3 Threat of Substitution       4.4.4 Threat of New Entrants       4.4.5 Competitive Rivalry    4.5 Global Nicotinic Agonists Market Size & Forecast, 2020-2028       4.5.1 Nicotinic Agonists Market Size and Y-o-Y Growth       4.5.2 Nicotinic Agonists Market Absolute $ Opportunity

Chapter 5 Global  Market Analysis and Forecast by Type
   5.1 Introduction
      5.1.1 Key Market Trends & Growth Opportunities by Type
      5.1.2 Basis Point Share (BPS) Analysis by Type
      5.1.3 Absolute $ Opportunity Assessment by Type
   5.2  Market Size Forecast by Type
      5.2.1 Nicotine
      5.2.2 Acetylcholine
      5.2.3 Carbachol
      5.2.4 Epibatidine
      5.2.5 Others
   5.3 Market Attractiveness Analysis by Type

Chapter 6 Global  Market Analysis and Forecast by Applications
   6.1 Introduction
      6.1.1 Key Market Trends & Growth Opportunities by Applications
      6.1.2 Basis Point Share (BPS) Analysis by Applications
      6.1.3 Absolute $ Opportunity Assessment by Applications
   6.2  Market Size Forecast by Applications
      6.2.1 Alzheimer's Disease (AD)
      6.2.2 Schizophrenia
      6.2.3 Others
   6.3 Market Attractiveness Analysis by Applications

Chapter 7 Global Nicotinic Agonists Market Analysis and Forecast by Region
   7.1 Introduction
      7.1.1 Key Market Trends & Growth Opportunities by Region
      7.1.2 Basis Point Share (BPS) Analysis by Region
      7.1.3 Absolute $ Opportunity Assessment by Region
   7.2 Nicotinic Agonists Market Size Forecast by Region
      7.2.1 North America
      7.2.2 Europe
      7.2.3 Asia Pacific
      7.2.4 Latin America
      7.2.5 Middle East & Africa (MEA)
   7.3 Market Attractiveness Analysis by Region

Chapter 8 Coronavirus Disease (COVID-19) Impact 
   8.1 Introduction 
   8.2 Current & Future Impact Analysis 
   8.3 Economic Impact Analysis 
   8.4 Government Policies 
   8.5 Investment Scenario

Chapter 9 North America  Analysis and Forecast
   9.1 Introduction
   9.2 North America  Market Size Forecast by Country
      9.2.1 U.S.
      9.2.2 Canada
   9.3 Basis Point Share (BPS) Analysis by Country
   9.4 Absolute $ Opportunity Assessment by Country
   9.5 Market Attractiveness Analysis by Country
   9.6 North America  Market Size Forecast by Type
      9.6.1 Nicotine
      9.6.2 Acetylcholine
      9.6.3 Carbachol
      9.6.4 Epibatidine
      9.6.5 Others
   9.7 Basis Point Share (BPS) Analysis by Type 
   9.8 Absolute $ Opportunity Assessment by Type 
   9.9 Market Attractiveness Analysis by Type
   9.10 North America  Market Size Forecast by Applications
      9.10.1 Alzheimer's Disease (AD)
      9.10.2 Schizophrenia
      9.10.3 Others
   9.11 Basis Point Share (BPS) Analysis by Applications 
   9.12 Absolute $ Opportunity Assessment by Applications 
   9.13 Market Attractiveness Analysis by Applications

Chapter 10 Europe  Analysis and Forecast
   10.1 Introduction
   10.2 Europe  Market Size Forecast by Country
      10.2.1 Germany
      10.2.2 France
      10.2.3 Italy
      10.2.4 U.K.
      10.2.5 Spain
      10.2.6 Russia
      10.2.7 Rest of Europe
   10.3 Basis Point Share (BPS) Analysis by Country
   10.4 Absolute $ Opportunity Assessment by Country
   10.5 Market Attractiveness Analysis by Country
   10.6 Europe  Market Size Forecast by Type
      10.6.1 Nicotine
      10.6.2 Acetylcholine
      10.6.3 Carbachol
      10.6.4 Epibatidine
      10.6.5 Others
   10.7 Basis Point Share (BPS) Analysis by Type 
   10.8 Absolute $ Opportunity Assessment by Type 
   10.9 Market Attractiveness Analysis by Type
   10.10 Europe  Market Size Forecast by Applications
      10.10.1 Alzheimer's Disease (AD)
      10.10.2 Schizophrenia
      10.10.3 Others
   10.11 Basis Point Share (BPS) Analysis by Applications 
   10.12 Absolute $ Opportunity Assessment by Applications 
   10.13 Market Attractiveness Analysis by Applications

Chapter 11 Asia Pacific  Analysis and Forecast
   11.1 Introduction
   11.2 Asia Pacific  Market Size Forecast by Country
      11.2.1 China
      11.2.2 Japan
      11.2.3 South Korea
      11.2.4 India
      11.2.5 Australia
      11.2.6 South East Asia (SEA)
      11.2.7 Rest of Asia Pacific (APAC)
   11.3 Basis Point Share (BPS) Analysis by Country
   11.4 Absolute $ Opportunity Assessment by Country
   11.5 Market Attractiveness Analysis by Country
   11.6 Asia Pacific  Market Size Forecast by Type
      11.6.1 Nicotine
      11.6.2 Acetylcholine
      11.6.3 Carbachol
      11.6.4 Epibatidine
      11.6.5 Others
   11.7 Basis Point Share (BPS) Analysis by Type 
   11.8 Absolute $ Opportunity Assessment by Type 
   11.9 Market Attractiveness Analysis by Type
   11.10 Asia Pacific  Market Size Forecast by Applications
      11.10.1 Alzheimer's Disease (AD)
      11.10.2 Schizophrenia
      11.10.3 Others
   11.11 Basis Point Share (BPS) Analysis by Applications 
   11.12 Absolute $ Opportunity Assessment by Applications 
   11.13 Market Attractiveness Analysis by Applications

Chapter 12 Latin America  Analysis and Forecast
   12.1 Introduction
   12.2 Latin America  Market Size Forecast by Country
      12.2.1 Brazil
      12.2.2 Mexico
      12.2.3 Rest of Latin America (LATAM)
   12.3 Basis Point Share (BPS) Analysis by Country
   12.4 Absolute $ Opportunity Assessment by Country
   12.5 Market Attractiveness Analysis by Country
   12.6 Latin America  Market Size Forecast by Type
      12.6.1 Nicotine
      12.6.2 Acetylcholine
      12.6.3 Carbachol
      12.6.4 Epibatidine
      12.6.5 Others
   12.7 Basis Point Share (BPS) Analysis by Type 
   12.8 Absolute $ Opportunity Assessment by Type 
   12.9 Market Attractiveness Analysis by Type
   12.10 Latin America  Market Size Forecast by Applications
      12.10.1 Alzheimer's Disease (AD)
      12.10.2 Schizophrenia
      12.10.3 Others
   12.11 Basis Point Share (BPS) Analysis by Applications 
   12.12 Absolute $ Opportunity Assessment by Applications 
   12.13 Market Attractiveness Analysis by Applications

Chapter 13 Middle East & Africa (MEA)  Analysis and Forecast
   13.1 Introduction
   13.2 Middle East & Africa (MEA)  Market Size Forecast by Country
      13.2.1 Saudi Arabia
      13.2.2 South Africa
      13.2.3 UAE
      13.2.4 Rest of Middle East & Africa (MEA)
   13.3 Basis Point Share (BPS) Analysis by Country
   13.4 Absolute $ Opportunity Assessment by Country
   13.5 Market Attractiveness Analysis by Country
   13.6 Middle East & Africa (MEA)  Market Size Forecast by Type
      13.6.1 Nicotine
      13.6.2 Acetylcholine
      13.6.3 Carbachol
      13.6.4 Epibatidine
      13.6.5 Others
   13.7 Basis Point Share (BPS) Analysis by Type 
   13.8 Absolute $ Opportunity Assessment by Type 
   13.9 Market Attractiveness Analysis by Type
   13.10 Middle East & Africa (MEA)  Market Size Forecast by Applications
      13.10.1 Alzheimer's Disease (AD)
      13.10.2 Schizophrenia
      13.10.3 Others
   13.11 Basis Point Share (BPS) Analysis by Applications 
   13.12 Absolute $ Opportunity Assessment by Applications 
   13.13 Market Attractiveness Analysis by Applications

Chapter 14 Competition Landscape 
   14.1 Nicotinic Agonists Market: Competitive Dashboard
   14.2 Global Nicotinic Agonists Market: Market Share Analysis, 2019
   14.3 Company Profiles (Details – Overview, Financials, Developments, Strategy) 
      14.3.1 FORUM Pharmaceuticals
      14.3.2 Karuna Pharmaceuticals
      14.3.3 Sumitomo Dainippon Pharma Co
      14.3.4 BMS
      14.3.5 Oyster Point Pharma
      14.3.6 Jiangsu Hansoh Pharmaceutical
      14.3.7 Dalian Meilun Biotech Co

Our Trusted Clients

Contact Us